Profitability
Weight: 25%
B
70
- 5yr Avg ROIC 9.6%
- Operating Margin Trend +3.27 pp/yr
NBIX
Neurocrine Biosciences, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
C+
58
- 5yr Avg ROE 10.9%
- 5yr Share-Count CAGR 0.9%
Growth Quality
Weight: 25%
B+
78
- 5yr Revenue CAGR 22.3%
- 5yr EPS CAGR 2.3%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A
88
- 5yr FCF Margin 22.2%
- 5yr FCF/NI Conversion 1.87x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -1.60x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 8.35
Stability
Weight: 5%
C-
46
- EPS Volatility (σ/μ) 0.77
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 2 added; 1 trimmed.
- Holders
- 3
- Avg Δ position
- -17.2%
- New buys
- 0
- Full exits
- 0
- Cooperman decreased -94%
- Dalio increased +39%
- Greenblatt increased +3%